Archived 48: Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration [December 9, 2022]

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2022) on “Archived 48: Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration [December 9, 2022]”. The use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration: Methods, epidemiology, hybrid immunity, seroprevalence, and more.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.